Non-invasive assessment of hepatic fibrosis among patients with chronic hepatitis B virus infection in three tertiary hospitals in Nigeria.

Autor: Oluwagbenga OO; Department of Medicine, Afe Babalola University Ado-Ekiti, Ado-Ekiti, Ekiti State, Nigeria.; Department of Medicine, Federal Teaching Hospital Ido-Ekiti, Ido-Ekiti, Ekiti State, Nigeria.; Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria., Lukman Olaitan A; Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria.; Department of Internal Medicine, University of Abuja Teaching Hospital Gwagwalada, Abuja, Federal Capital Territory, Nigeria., Ihiovi UB; Department of Internal Medicine, Federal Teaching Hospital Lokoja, Lokoja, Kogi State, Nigeria., Gideon OO; Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria.; Department of Medical Laboratory Sciences, Faculty of Basic Sciences, Redeemers University Ede, Ede, Osun State, Nigeria.; Department of Medical Services, Hospitals Management Board, Ado-Ekiti, Ekiti State, Nigeria., Maryjoy II; Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria.; Center for Translation and Implementation Research, College of Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria.; Department of Medical Laboratory Sciences, Faculty of Health Sciences and Technology, University of Nigeria Enugu Campus, Enugu, Enugu State, Nigeria., Elijah AO; Department of Medicine, Afe Babalola University Ado-Ekiti, Ado-Ekiti, Ekiti State, Nigeria.; Department of Medicine, Federal Teaching Hospital Ido-Ekiti, Ido-Ekiti, Ekiti State, Nigeria.; Enlightenment Initiative on Viral Hepatitis, Ede, Osun State, Nigeria., Samson JO; Division of Global Public Health, Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, CA, USA., Adenike OO; Department of Medicine, Afe Babalola University Ado-Ekiti, Ado-Ekiti, Ekiti State, Nigeria.; Department of Medicine, Federal Teaching Hospital Ido-Ekiti, Ido-Ekiti, Ekiti State, Nigeria.

Publikováno v: SAGE open medicine [SAGE Open Med] 2024 Aug 07; Vol. 12, pp. 20503121241264313. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).

Glycerol-weighted chemical exchange saturation transfer nanoprobes allow ¹⁹ F ^/1 H dual-modality magnetic resonance imaging-guided cancer radiotherapy.

Autor: A R; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Wang H; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Nie C; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Han Z; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Zhou M; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Atinuke OO; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Wang K; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Wang X; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Liu S; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Zhao J; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Qiao W; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Sun X; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Wu L; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China., Sun X; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Heilongjiang Province, China. sunxl@ems.hrbmu.edu.cn.; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Heilongjiang Province, China. sunxl@ems.hrbmu.edu.cn.

Publikováno v: Nature communications [Nat Commun] 2023 Oct 20; Vol. 14 (1), pp. 6644. Date of Electronic Publication: 2023 Oct 20.

Bio-accessibility and health risk assessment of some selected heavy metals in indoor dust from higher institutions in Ondo State, Nigeria.

Autor: Ajayi OO; Department of Chemistry, Federal University of Technology, Akure, Nigeria. Duroyem96@gmail.com., Aborode AT; Department of Chemistry, Mississippi State University, Starkville, USA., Orege JI; University of Chinese Academy of Sciences, Beijing, China.; Department of Industrial Chemistry, Ekiti State University, PMB 5363, Ado Ekiti, Nigeria., Oyewumi TO; Department of Chemistry, Federal University of Technology, Akure, Nigeria., Othmani A; Faculty of Sciences of Monastir, University of Monastri, Avenue of the Environment, 5019, Monastir, Tunisia., Adegbola MA; Department of Zoology and Environmental Biology, Ekiti State University, PMB 5363, Ado Ekiti, Nigeria., Orege OB; Department of Chemistry, University of Ibadan, Ibadan, Oyo State, Nigeria.

Publikováno v: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2023 Feb; Vol. 30 (10), pp. 25256-25264. Date of Electronic Publication: 2022 Jul 21.

Knowledge of the coronavirus disease 2019 (COVID-19) and sleep problems among a selected sample of psychiatric hospital staff in Nigeria: a cross-sectional study.

Autor: Oderinde KO; Department of Mental Health, University of Benin Teaching Hospital, Benin City, Nigeria., Akanni OO; Forensic Unit, Federal Neuro-Psychiatric Hospital, Benin City, Nigeria., Olashore A; Department of Psychiatry, University of Botswana, Gaborone, Botswana.

Publikováno v: The Pan African medical journal [Pan Afr Med J] 2021 Sep 15; Vol. 40, pp. 39. Date of Electronic Publication: 2021 Sep 15 (Print Publication: 2021).

Precise Cancer Anti-acid Therapy Monitoring Using pH-Sensitive MnO 2 @BSA Nanoparticles by Magnetic Resonance Imaging.

Autor: A R; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Yao Y; National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China., Guo X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China., Jiang W; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Jiang M; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Yang J; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Li Y; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Atinuke OO; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Hu X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Li Y; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Wang X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China., Yang L; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China., Yang X; National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China., Wang K; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China., Hu J; National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China., Sun X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Apr 28; Vol. 13 (16), pp. 18604-18618. Date of Electronic Publication: 2021 Apr 15.